Highly metastatic cancer cells expressing high levels of the full-length ATP13A3 protein are sensitive to polyamine targeted therapies and respond to polyamine stimuli by altering the cellular localization of ATP13A3. The gene discussed is ATP13A3; the disease is cancer.